AA,
The initial criteria used in the adjuvant clinical trials included the "2 year rule". BUT there is nothing in the Herceptin Labeling or "boxed Label" which places this restriction on patients. It is solely up to the prescribing oncologist:
Here is the "official" labeling
http://www.gene.com/gene/products/in...rescribing.pdf
Regards
Joe